ストックスクリーナーアプリを入手
42.01
1.83%
0.755
アフターアワーズ：
41.96
-0.045
-0.11%
前日終値:
$41.25
開ける：
$41.26
24時間の取引高:
518.01K
Relative Volume:
1.26
時価総額：
$3.18B
収益：
$384.10M
当期純損益:
$-9.07M
株価収益率:
-300.04
EPS:
-0.14
ネットキャッシュフロー:
$11.10M
1週間 パフォーマンス:
+0.01%
1か月 パフォーマンス:
+4.83%
6か月 パフォーマンス:
+53.08%
1年 パフォーマンス:
+110.66%
1日の値動き範囲:
$40.95
$42.90
1週間の範囲:
$40.52
$42.90
52週間の値動き範囲:
$17.82
$44.42
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
名前
Kiniksa Pharmaceuticals International Plc
セクター
電話
(781) 431-9100
住所
23 OLD BOND STREET, FLOOR 3, LONDON
KNSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
42.01 | 3.13B | 384.10M | -9.07M | 11.10M | -0.14 |
|
ZTS
Zoetis Inc
|
125.90 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-29 | 開始されました | TD Cowen | Buy |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2024-09-13 | 開始されました | Jefferies | Buy |
| 2024-05-03 | 開始されました | Wells Fargo | Overweight |
| 2020-06-29 | 繰り返されました | BofA Securities | Buy |
| 2020-04-01 | 開始されました | BofA/Merrill | Buy |
| 2019-03-11 | 開始されました | Barclays | Overweight |
| 2018-12-12 | 繰り返されました | Wedbush | Outperform |
| 2018-06-19 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Kiniksa Pharmaceuticals International Plc (KNSA) 最新ニュース
Rice Hall James & Associates LLC Reduces Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA) - Finviz
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High – Time to Buy? - Defense World
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Barry Quart Sells 20,129 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - Defense World
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $500,714.88 in Stock - MarketBeat
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $500,715, According to a Recent SEC Filing - marketscreener.com
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $835,555, According to a Recent SEC Filing - marketscreener.com
Kiniksa Pharmaceuticals Executives Sell Shares - TradingView — Track All Markets
Kiniksa Pharmaceuticals (KNSA) director records option exercise and share sale - Stock Titan
Kiniksa Pharmaceuticals (KNSA) COO reports option exercise and share sale - Stock Titan
US High Growth Tech Stocks to Watch - simplywall.st
Braidwell LP Sells 860,329 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Why Kiniksa Pharmaceuticals International, plc (KNSA) is Poised to Beat Earnings Estimates Again - MSN
Nebula Research & Development LLC Has $1.93 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells 42,841 Shares of Stock - MarketBeat
Kiniksa Pharma CFO Ragosa sells shares worth $1.77m By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals CFO Sells Shares - TradingView — Track All Markets
Jump Financial LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by Walleye Capital LLC - MarketBeat
Arrowstreet Capital Limited Partnership Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Fisher Asset Management LLC Has $2.83 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Wedbush Reiterates Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat
Traders Buy High Volume of Call Options on Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat
Franklin Resources Inc. Acquires 41,632 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kiniksa (KNSA) Q3 2025 Earnings Call Transcript - The Globe and Mail
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet - MSN
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighTime to Buy? - MarketBeat
AXQ Capital LP Makes New $289,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
200,574 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Hillsdale Investment Management Inc. - MarketBeat
Catalyst Funds Management Pty Ltd Takes $493,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 12,470 Shares of Stock - MarketBeat
SG Americas Securities LLC Acquires 127,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharma COO Tessari sells shares worth $514,224 By Investing.com - Investing.com South Africa
Kiniksa Pharma COO Tessari sells shares worth $514,224 - Investing.com
[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighTime to Buy? - MarketBeat
Los Angeles Capital Management LLC Sells 36,570 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Jefferies London Healthcare Conference 2025Slideshow (NASDAQ:KNSA) 2025-11-18 - Seeking Alpha
Savant Capital LLC Invests $398,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Mark Ragosa Sells 19,900 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Rides ARCALYST Growth To Outpace The S&P 500 - Finimize
Kiniksa Pharmaceuticals International Plc (KNSA) 財務データ
収益
当期純利益
現金流量
EPS
Kiniksa Pharmaceuticals International Plc (KNSA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Quart Barry D | Director |
Dec 15 '25 |
Sale |
41.51 |
20,129 |
835,555 |
12,546 |
| Tessari Eben | CHIEF OPERATING OFFICER |
Dec 15 '25 |
Option Exercise |
8.83 |
6,000 |
52,980 |
28,714 |
| Tessari Eben | CHIEF OPERATING OFFICER |
Dec 15 '25 |
Sale |
41.56 |
12,048 |
500,715 |
16,666 |
2.19%
0.08%
大文字化:
|
ボリューム (24 時間):